Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 0.0 | BCD100322A002 | 29.8 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 0.5 | BCD100322A005 | 20.7 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 1.0 | BCD100322A009 | 23.4 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 2.0 | BCD100322A013 | 22.8 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 4.0 | BCD100322A017 | 21.5 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 8.0 | BCD100322A021 | 17.1 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 12.0 | BCD100322A025 | 21.2 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | Lipid-depleted/compactin | 24.0 | BCD100322A029 | 23.6 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 0.0 | BCD100322A001 | 26.7 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 0.5 | BCD100322A003 | 24.7 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 1.0 | BCD100322A007 | 29 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 2.0 | BCD100322A011 | 20.5 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 4.0 | BCD100322A015 | 32.8 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 8.0 | BCD100322A019 | 33.5 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 12.0 | BCD100322A023 | 25.1 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | C | 24.0 | BCD100322A027 | 35.2 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A006 | 26 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A010 | 22.7 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A014 | 20.6 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A018 | 17.4 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A022 | 21.6 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A026 | 35.6 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A030 | 22.4 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 0.5 | BCD100322A004 | 22.8 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 1.0 | BCD100322A008 | 16.9 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 2.0 | BCD100322A012 | 21.6 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 4.0 | BCD100322A016 | 22.8 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 8.0 | BCD100322A020 | 23.5 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 12.0 | BCD100322A024 | 26.8 | pmol/sample |
| LMFA01030184 | 7,10,13,16,19-docosapentaenoic acid | 25OH-Chol | 24.0 | BCD100322A028 | 14 | pmol/sample |